Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL41543 | 0.96 | CYP3A4 (0.39) | CYP3A4TDP1ALDH1A1TP53TAAR1 | |
| Hydrochloric Acid SCHEMBL71899 | 0.94 | CYP3A4 (0.37) | CYP3A4TDP1ALDH1A1TP53TAAR1 | |
| Water SCHEMBL28537381 | 0.94 | CYP3A4 (0.37) | CYP3A4TDP1ALDH1A1TP53TAAR1 | |
| Hydrochloric Acid SCHEMBL3286109 | 0.94 | CYP3A4 (0.37) | CYP3A4TDP1ALDH1A1TP53TAAR1 | |
| Hydrochloric Acid SCHEMBL28977209 | 0.93 | CYP3A4 (0.36) | CYP3A4TDP1ALDH1A1TP53TAAR1 | |
| Hydrochloric Acid SCHEMBL21357686 | 0.93 | CYP3A4 (0.36) | CYP3A4TDP1ALDH1A1TP53TAAR1 | |
| Hydrochloric Acid SCHEMBL557242 | 0.93 | CYP3A4 (0.36) | CYP3A4TDP1ALDH1A1TP53TAAR1 | |
| Carbon Tetrachloride SCHEMBL29029110 | 0.89 | ALDH1A1 (0.33) | CYP3A4TDP1ALDH1A1TP53 | |
| SCHEMBL5803242 | 0.85 | CYP3A4 (0.49) | CYP3A4HSD17B10 | |
| SCHEMBL22289155 | 0.81 | GRM8 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107849533-A | Use of mesenchymal stem cells for the treatment of osteoarthritis | 洪士杰 | 2018-03-27 | — | — | CN | disclosed |
| US-9775930-B2 | Composition for modifying myocardial infarction expansion | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2017-10-03 | — | — | US | disclosed |
| US-20170258961-A9 | COMPOSITION FOR MODIFYING MYOCARDIAL INFARCTION EXPANSION | ABBOTT CARDIOVASCULAR SYSTEMS INC (US) | 2017-09-14 | — | — | US | disclosed |
| EP-2452699-B1 | Scaffolding for modifying myocardial infarction expansion | ABBOTT CARDIOVASCULAR SYSTEMS (US) | 2016-04-20 | — | — | EP | disclosed |
| US-20150209473-A1 | METHODS OF MODIFYING MYOCARDIAL INFARCTION EXPANSION | ABBOTT CARDIOVASCULAR SYSTEMS (US) | 2015-07-30 | — | — | US | disclosed |
| US-9005672-B2 | Methods of modifying myocardial infarction expansion | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2015-04-14 | — | — | US | disclosed |
| EP-2109469-B1 | METHODS OF MODIFYING MYOCARDIAL INFARCTION EXPANSION | ABBOTT CARDIOVASCULAR SYSTEMS (US) | 2014-06-04 | — | — | EP | disclosed |
| EP-2452699-A1 | Methods of modifying myocardial infarction expansion | Abbott Cardiovascular Systems Inc. (US) | 2012-05-16 | — | — | EP | disclosed |
| EP-2109469-A2 | METHODS OF MODIFYING MYOCARDIAL INFARCTION EXPANSION | Abbott Cardiovascular Systems Inc. (US) | 2009-10-21 | — | — | EP | disclosed |
| US-20090022817-A1 | METHODS OF MODIFYING MYOCARDIAL INFARCTION EXPANSION | MICHAL EUGENE T | 2009-01-22 | — | — | US | disclosed |
| WO-2008089452-A2 | METHODS OF MODIFYING MYOCARDIAL INFARCTION EXPANSION | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2008-07-24 | — | — | WO | disclosed |
| US-5807556-A | ADMINISTERING FIBROBLAST GROWTH FACTOR AND ELECTRICAL STIMULATION | THOMAS JEFFERSON UNIVERSITY (US) | 1998-09-15 | — | — | US | disclosed |
| EP-0385415-B1 | Process for producing NADH oxidase | MITSUBISHI PETROCHEMICAL CO (JP) | 1995-06-07 | — | — | EP | disclosed |
| US-5416012-A | Process for producing NADH oxidase | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1995-05-16 | — | — | US | disclosed |
| US-5336608-A | Culturing a genetically engineered alkalophilic, facultative anaerobic bacterium | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1994-08-09 | — | — | US | disclosed |
| EP-0385415-A1 | Process for producing NADH oxidase | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1990-09-05 | — | — | EP | disclosed |